Finally, we identified a series of CLL patients with divergent levels of serum TNFα (n = 12) and compared the abilities of M-MDSCs from these to suppress autologous T-cell growth in vitro. The gene discussed is TNF; the disease is B-cell chronic lymphocytic leukemia.